Systematic immune responses, including elevation of enhanced DC maturation and cytokine secretion, as well as the upregulation of the activation of CD8+ T cells and NK cells, have been shown to contribute to the enhanced comprehensive SIT against malignant tumors. This evidence concerns the gene CD8A and cancer.